About CJC-1295
A long-acting Growth Hormone Releasing Hormone (GHRH) analog studied for sustained GH and IGF-1 elevations.
Research dose ranges
- Dose: 100–300 mcg per administration
- Frequency: 1× per day
- Route: subcutaneous
- Half-life: ~8 hours
- Cycle: 8 weeks on / 4 off
CJC-1295 no-DAC is typically used at 100 mcg up to 3× daily; CJC-1295 with DAC is used once or twice weekly at 1–2 mg.
Storage
Lyophilized stable at 2–8°C. Reconstituted product should be refrigerated.